As of 2023, Chugai Pharmaceutical has disclosed 6 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 6 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Chugai Pharmaceutical ’s climate strategy, ambition level, and alignment with global decarbonization goals.
Target Type | Scope of Target | Unit | Target | Target Year |
---|---|---|---|---|
Absolute-based Target* | Scope 1 - Process | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data. | 2025 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data. | 2025 |
Absolute-based Target* | Scope 1 - Process | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data. | 2030 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data. | 2030 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data. | 2030 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data. | 2050 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
As of 2023, Chugai Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.
As of 2023, Chugai Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Chugai Pharmaceutical's most ambitious operational target is to reduce these emissions by 100% by 2030, compared to a baseline of 736 Metric Tonnes of CO2 equivalent (mtCO2e) in 2020.
As of 2023, Chugai Pharmaceutical is ahead of schedule on its operational emissions reduction target, having achieved 35.33% of the planned reduction.
As of 2023, Chugai Pharmaceutical has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.
Chugai Pharmaceutical's most ambitious value chain target is to reduce these emissions by 30% by 2030, compared to a baseline of 964,000 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019.
Instead of reducing value chain emissions, Chugai Pharmaceutical has increased them, with 2023 levels exceeding those of the 2019 baseline, placing the company well behind its reduction target.